Gabelli Funds LLC Biogen Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Biogen Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 14,100 shares of BIIB stock, worth $2.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,100

Previous 14,400 2.08%

Holding current value

$2.2 Million

Previous $3.34 Million 18.12%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $56,721 - $71,040	-300 Reduced 2.08%	14,100 $2.73 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $57,156 - $71,016	-300 Reduced 2.04%	14,400 $3.34 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $15,581 - $18,755	-70 Reduced 0.47%	14,700 $3.8 Million
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $55,726 - $62,895	220 Added 1.51%	14,770 $3.8 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $55,050 - $63,612	-200 Reduced 1.36%	14,550 $4.14 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $44,898 - $51,159	-175 Reduced 1.17%	14,750 $4.1 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $6,311 - $7,668	25 Added 0.17%	14,925 $4.13 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $77,876 - $107,383	-400 Reduced 2.61%	14,900 $3.98 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $42,196 - $50,179	225 Added 1.49%	15,300 $3.12 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $92,926 - $119,424	-415 Reduced 2.68%	15,075 $3.62 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $38,203 - $49,821	135 Added 0.88%	15,490 $4.38 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $150,220 - $240,531	580 Added 3.93%	15,355 $5.32 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $42,516 - $49,810	175 Added 1.2%	14,775 $4.13 Million
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $94,504 - $142,252	-400 Reduced 2.67%	14,600 $3.58 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $52,954 - $61,141	-200 Reduced 1.32%	15,000 $4.26 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $38,799 - $51,382	-150 Reduced 0.98%	15,200 $4.07 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $40,327 - $51,156	-150 Reduced 0.97%	15,350 $4.86 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $44,012 - $60,814	-200 Reduced 1.27%	15,500 $4.6 Million
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $65,232 - $73,164	-300 Reduced 1.88%	15,700 $3.66 Million
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $585,117 - $915,192	-2,700 Reduced 14.44%	16,000 $3.78 Million
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $250,650 - $317,475	-900 Reduced 4.59%	18,700 $5.63 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $176,106 - $230,298	-600 Reduced 2.97%	19,600 $6.93 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $3.33 Million - $4.71 Million	-12,800 Reduced 38.79%	20,200 $5.53 Million
Q3 2017 Nov 01, 2017	BUY	$281.15 - $329.69 $9.28 Million - $10.9 Million	33,000	33,000 $10.3 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Biogen Inc. Transaction History